
















96The impact of intraoperative shunting on early
neurologic outcomes after carotid endarterectomy
Kyla M. Bennett, MD, John E. Scarborough, MD, Mitchell W. Cox, MD, and Cynthia K. Shortell, MD,
Durham, NC
Background: Although the need for intraoperative shunting during carotid endarterectomy (CEA) is intensely debated,
relatively few studies have compared the neurologic outcomes of patients undergoing CEA with or without shunts. The
objective of our analysis was to determine the impact of intraoperative shunting during CEA on the incidence of post-
operative stroke.
Methods: The 2012 CEA-targeted American College of Surgeons National Surgical Quality Improvement Program
database was used for this analysis. The preoperative and operative characteristics of patients undergoing CEA with or
without intraoperative shunting were compared. From this overall sample, propensity score techniques were then used to
match patients with or without intraoperative shunting for a number of variables, including age, degree of ipsilateral and
contralateral carotid stenosis, presence of several anatomic or physiologic risk factors, anesthesia modality, and use of
patch angioplasty vs primary arteriotomy closure. The 30-day postoperative mortality and combined stroke/transient
ischemic attack (TIA) rates of this matched cohort were then compared. A similar analysis was also performed on a
subgroup of patients with severe stenosis or occlusion of the contralateral carotid artery.
Results: A total of 3153 patients were included for initial analysis (2023 “no-shunt” patients vs 1130 “shunt” patients).
From this overall sample, propensity score matching yielded a cohort of 1072 patients with or without intraoperative shunt
placement who were well matched for all known patient- and procedure-related factors. There was no signiﬁcant difference
in the incidence of postoperative stroke/TIA between the two groups of this matched cohort (3.4% in the no-shunt group vs
3.7% in the shunt group; P [ .64). Analysis of a similarly well matched subgroup of patients with severe stenosis or oc-
clusion of the contralateral carotid artery demonstrated a statistically nonsigniﬁcant increase in the incidence of postoperative
stroke/TIA with the use of intraoperative shunting (4.9% in the no-shunt group vs 9.8% in the shunt group; P [ .08).
Conclusions: There is no clinical beneﬁt to intraoperative shunting during CEA, even in patients who may be at high risk
for intraoperative cerebral hypoperfusion due to severe stenosis or occlusion of the contralateral carotid artery. (J Vasc
Surg 2015;61:96-102.)Whether intraoperative shunting should be used
routinely, selectively, or not at all during carotid endarterec-
tomy (CEA) is controversial. Some surgeons argue that
routine shunt use minimizes the risk of ipsilateral cerebral
hypoperfusion during carotid arterial clamping and enables
endarterectomy to be performed in an unhurriedmanner.1,2
Other surgeons argue that shunt use is unnecessary both
because cerebral hypoperfusion is a relatively uncommon
cause of perioperative stroke in patients who undergo CEA
and because the actual placement of a shunt can precipitate
carotid arterial injury or the generation of distal emboli.3-5
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://dx.doi.org/10.1016/j.jvs.2014.06.105in those patients who show evidence of neurophysiologic
derangement or inadequate carotid arterial backﬂow during
test-clamping of the ipsilateral internal carotid artery (ICA)
because such a strategy allows the theoretical beneﬁts of
shunting for high-risk patients but avoids the potential com-
plications of shunt placement in low-risk patients.2,6
In addition to these theoretical arguments, proponents
of each of the three shunting (or nonshunting) strategies
can also cite multiple single-center case series from the
literature demonstrating that their preferred approach can
be pursued with an acceptably low incidence of periopera-
tive stroke, even in the setting of high-risk conditions such
as contralateral carotid occlusion.2,4,7-14 To date, relatively
few studies have been published in which the early neuro-
logic outcomes of patients undergoing CEA with or
without shunting have been directly compared, and the
collective results of these studies do not clearly favor or
disfavor any one of the three potential approaches to shunt
use.2,6,9,15-18
The recent development of “procedure-targeted” data
repositories by the American College of Surgeons National
Surgical Quality Improvement Program (ACS NSQIP) of-
fers a unique opportunity to contribute further to our
knowledge about speciﬁc questions such as the need for
shunting during CEA.19 Unlike previous ACS NSQIP
data ﬁles, the procedure-speciﬁc databases contain informa-
tion about risk factors and outcomes that may be of unique
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are frequently performed. For example, the CEA-targeted
database contains information about variables such as intra-
operative shunt and a host of other variables of speciﬁc in-
terest in assessing the early outcomes after CEA. On the
basis of the theoretical rationale for shunt use, we hypoth-
esized that shunted patients would have a lower incidence
of perioperative stroke than otherwise similar patients who
did not undergo intraoperative shunting.
METHODS
The 2012 ACS NSQIP Procedure Targeted Carotid
Open Participant Use Data File (PUF) and the larger
2012 ACS NSQIP Participant User File were merged to
perform this analysis. The larger data set contains informa-
tion about 543,885 general and subspecialty procedures
(including CEA) performed at 374 participating academic
and community hospitals in the United States.20 Because
larger hospitals may not be able to capture all of the surgi-
cal cases that meet the ACS NSQIP inclusion criteria, a sys-
tematic sampling system is used to prevent bias in choosing
cases for assessment. The database is therefore not popula-
tion based. Information captured in the larger data set
includes patient demographics, comorbid illnesses, periop-
erative variables, and 30-day postoperative mortality and
morbidity data. Each variable included within the database
is strictly deﬁned to ensure uniformity, and the information
about each variable is prospectively collected by on-site
ACS-trained clinical reviewers. Periodic auditing of these
reviewers has demonstrated the data contained within the
database to be highly reliable, with interobserver disagree-
ment occurring at a rate of only 2%.20 The 2012 CEA-
targeted database contains more detailed disease- and
procedure-speciﬁc information about select patients from
the larger data set who underwent CEA. In 2012, 78 cen-
ters participated in the CEA-targeted ACS NSQIP pro-
gram. The additional information that is available in the
CEA-targeted database includes the degree of ipsilateral
and contralateral carotid arterial occlusion, the presence
and type of preoperative symptoms that were present and
attributable to carotid stenosis, and the intraoperative use
of carotid shunts.20 Neither the larger ACS NSQIP PUF
nor the CEA-targeted PUF contains hospital identiﬁers.
It is therefore not possible to determine center-speciﬁc in-
formation, such as annual CEA volume or center-speciﬁc
postoperative outcomes.
Patients from this data source were included for anal-
ysis if they were documented to have undergone any of
the following procedures: CEA, CEA with shunt, CEA
with patch angioplasty, or CEA with patch angioplasty
and shunt. Patients who underwent eversion CEA (in
whom the use or nonuse of a shunt was not documented
by the ACS NSQIP) or in whom the procedure type was
not documented were excluded from analysis. Patients
were also excluded from analysis if they had missing data
for any of the variables included for analysis.
The primary predictor variable for our analysis was the
presence or absence of an intraoperative shunt duringCEA.Other predictor variables used in our analysis included
the following: the patient’s age and gender; the presence of
one or more physiologic high-risk factors, including class III
or IV New York Heart Association congestive heart failure,
left ventricular ejection fraction <30%, unstable angina
within 30 days before surgery, or myocardial infarction
within 30 days before surgery; bleeding disorder, including
the ongoing use of anticoagulation therapy immediately
before surgery; ipsilateral ICA stenosis$80% as determined
by preoperative Doppler ultrasound, computed tomogra-
phy angiography, or magnetic resonance angiography; pres-
ence of contralateral ICA occlusion as determined by
preoperative imaging; presence of preoperative neurologic
symptoms, classiﬁed for the purposes of this analysis as
none/asymptomatic, ipsilateral transient ischemic attack
(TIA) or amaurosis fugax, or ipsilateral cerebrovascular acci-
dent; preprocedural antiplatelet therapy; preprocedural
statin therapy; preprocedural b-blocker therapy; presence
of one or more anatomic high-risk factors, including previ-
ous ipsilateral CEA/carotid stenting, previous ipsilateral
radical neck dissection, contralateral common carotid or
ICA occlusion, prior radiation to neck, contralateral laryn-
geal nerve injury or palsy, and anatomic lesion at the second
cervical vertebral level or higher; use of locoregional anes-
thesia (vs general anesthesia); operative time; and use of
patch angioplasty for closure of the carotid arteriotomy.
The primary outcomes for our analysis were 30-day postop-
erative mortality rate and the combined 30-day incidence of
postoperative stroke/TIA. These outcomes are determined
by an ACS-trained clinical nurse reviewer, who documents
the presence of an adverse postoperative event if there is
any mention of that event in the reviewer’s prospective re-
view of a patient’s medical record or discharge summary.20
The secondary outcome for our analysis was the day of diag-
nosis of postoperative stroke/TIA (in those patients who
sustained such an event), which was classiﬁed as either the
day of operation (and therefore potentially the result of
intraoperative cerebral hypoperfusion related to carotid
arterial clamping) or later.
With all patients from the 2012 Procedure Targeted
Carotid Open ACS NSQIP sample who had known data
for each of the predictor variables, including the degree
of contralateral ICA stenosis, univariate comparison of pa-
tient- and procedure-related characteristics and 30-day
postoperative outcomes of the “no-shunt” vs “shunt” pa-
tients was performed by Pearson c2 tests for categorical
variables and Wilcoxon rank sum tests for continuous vari-
ables. In an attempt to adjust for the fact that some sur-
geons place shunts only in those patients who they
perceive to be at high risk for intraoperative cerebral hypo-
perfusion, we next conducted a separate analysis using a
subset of the entire ACS NSQIP patient sample that was
matched on propensity for undergoing the procedure
with intraoperative shunting. For this analysis, a logistic
regression model was created to estimate the likelihood
of undergoing CEA with an intraoperative shunt. All of
the patient- and procedure-related variables were included
in this model as potential predictors of intraoperative
Table I. Patient- and procedure-related characteristics of patients undergoing carotid endarterectomy (CEA), stratiﬁed
by use of intraoperative shunting
All patients (N ¼ 3153) No shunt (n ¼ 2023) Shunt (n ¼ 1130) P value
Patient age, years, mean 6 SD 71.4 6 9.5 71.3 6 9.5 71.5 6 9.5 .77
Female 1215 (38.5) 746 (36.9) 469 (41.5) .01
Physiologic high-risk factors 131 (4.2) 89 (4.4) 42 (3.7) .36
Bleeding disorder 690 (21.9) 435 (21.5) 255 (22.6) .49
Ipsilateral ICA stenosis $80% 2159 (68.5) 1377 (68.1) 782 (69.2) .51
Type of preoperative symptoms .19
Asymptomatic 1813 (57.5) 1173 (58.0) 640 (56.6)
TIA or amaurosis fugax 756 (24.0) 494 (24.4) 262 (23.2)
Cerebrovascular accident 584 (18.5) 356 (17.6) 228 (20.2)
Contralateral ICA occlusion 149 (4.7) 73 (3.6) 76 (6.7) <.001
Preprocedural antiplatelet 2772 (87.9) 1772 (87.6) 1000 (88.5) .46
Preprocedural statin 2475 (78.5) 1598 (79.0) 877 (77.6) .37
Preprocedural b-blocker 1777 (56.4) 1169 (57.8) 608 (53.8) .03
Anatomic high-risk factors 397 (12.6) 253 (12.5) 144 (12.7) .85
Locoregional anesthesia 408 (12.9) 358 (17.7) 50 (4.4) <.001
Operative time, minutes, median (IQR) 116 (90-145) 117 (92-147) 113 (88-141) .01
Patch angioplasty 2659 (84.3) 1615 (79.8) 1044 (92.4) <.001
ICA, Internal carotid artery; IQR, interquartile range; SD, standard deviation; TIA, transient ischemic attack.
Data are presented as number (%) unless otherwise indicated.
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operative shunting that were derived from this regression
model were then used to calculate a propensity score for
intraoperative shunt use for each patient from the overall
study sample. This propensity score ranged from 0 to 1
and essentially represents the likelihood that a patient
would receive an intraoperative shunt on the basis of the
unique array of patient- and disease-related characteristics.
These propensity scores were then used to create an evenly
matched cohort of no-shunt and shunt patients by a caliper
matching algorithm (with caliper distance of 0.01), with
controls being used only once in the matching. The desired
result of this process was to pair as many shunt patients as
possible with a corresponding no-shunt patient who was
otherwise similar with respect to the comorbid and carotid
disease proﬁles. Comparisons of these characteristics and
the postoperative outcomes of this matched cohort of pa-
tients were then performed by McNemar c2 tests for binary
categorical variables, conditional logistic regression for
multilevel categorical variables, and Wilcoxon signed rank
sum test for continuous variables.
The analysis included all patients with known degree of
contralateral carotid artery stenosis. A second analysis was
then performed on the subset of patients from that cohort
who exhibited severe stenosis (80%-99%) or occlusion of
the contralateral ICA on preoperative imaging and in
whom intraoperative shunting would therefore be expected
to offer the greatest potential beneﬁt in reducing the inci-
dence of stroke due to intraoperative cerebral hypoperfu-
sion.21-23 All statistical analyses were performed with
Stata version 11.0 (StataCorp, College Station, Tex).
RESULTS
The 2012 CEA-targeted ACS NSQIP database con-
tains records from 4013 CEA procedures. Of this total,
860 were excluded from our analysis because of either theirundergoing eversion CEA (and in whom the use or nonuse
of a shunt could not be conﬁrmed; 215 patients) or missing
data for one or more of the variables considered in our
analysis (598 patients). The most common reason for
exclusion was missing data for the degree of contralateral
carotid artery stenosis (missing in 490 patients). A total
of 3151 meeting the inclusion and exclusion criteria of
our study were therefore included for analysis (2023 no-
shunt patients vs 1130 shunt patients). The patient- and
procedure-related characteristics of these patients are
shown in Table I. Patients in the shunt group were more
likely to be female, to have occlusion of the contralateral
ICA, and to have the carotid arteriotomy closed with a
patch. Patients in the no-shunt group were more likely to
undergo CEA with locoregional anesthesia. There was a
statistically but not clinically signiﬁcant difference in the
operative duration of procedures performed with and
without intraoperative shunting. The overall combined
30-day incidence of postoperative stroke/TIA was 3.7%
and did not differ on univariate comparison of the two
groups (3.6% for no-shunt patients vs 4.0% for shunt pa-
tients; P ¼ .55). The overall 30-day mortality rate was
0.9% and was higher for shunted patients (0.6% for no-
shunt patients vs 1.3% for shunt patients; P ¼ .05). Among
the 76 patients from our overall study sample who experi-
enced a postoperative stroke or TIA, the day of diagnosis of
the event was known for 64 (28 of 36 no-shunt patients
[78%] vs 36 of 40 shunt patients [90%]; P ¼ .32]. Univar-
iate comparison of these patients showed that a signiﬁcantly
greater proportion from the shunt group had the neuro-
logic event diagnosed on the day of operation compared
with patients from the no-shunt group (38.9% of shunt pa-
tients vs 17.9% of no-shunt patients; P ¼ .02).
A total of 2144 patients from the overall study sample
were matched on the basis of their propensity to undergo
intraoperative shunting during CEA. From the overall
Table II. Patient- and procedure-related characteristics of propensity-matched cohort of carotid endarterectomy (CEA)
patients, stratiﬁed by use of intraoperative shunting
No shunt (n ¼ 1072) Shunt (n ¼ 1072) P value
Patient age, years, mean 6 SD 71.7 6 9.4 71.4 6 9.5 .50
Female 447 (41.7) 437 (40.8) .64
Physiologic high-risk factors 40 (3.7) 40 (3.7) 1.0
Bleeding disorder 236 (22.0) 233 (21.7) .88
Ipsilateral ICA stenosis $80% 747 (69.7) 742 (69.2) .81
Type of preoperative symptoms .69
Asymptomatic 605 (56.4) 615 (57.4)
TIA or amaurosis fugax 249 (23.2) 254 (23.7)
Cerebrovascular accident 218 (20.3) 203 (18.9)
Contralateral ICA occlusion 53 (4.9) 50 (4.7) .66
Preprocedural antiplatelet 949 (88.5) 945 (88.2) .78
Preprocedural statin 815 (76.0) 837 (78.1) .27
Preprocedural b-blocker 583 (54.4) 586 (54.7) .89
Anatomic high-risk factors 122 (11.4) 126 (11.8) 1.0
Locoregional anesthesia 55 (5.1) 50 (4.7) .35
Operative time, minutes, median (IQR) 115 (91-143) 114 (88-142) .95
Patch angioplasty 983 (91.7) 986 (92.0) .67
ICA, Internal carotid artery; IQR, interquartile range; SD, standard deviation; TIA, transient ischemic attack.
Data are presented as number (%) unless otherwise indicated.
Fig 1. The 30-day postoperative mortality and combined stroke/
transient ischemic attack (TIA) rates for propensity-matched
cohort of carotid endarterectomy (CEA) patients, stratiﬁed by
use of intraoperative shunting. *Based on McNemar c2 test
comparing 1072 pairs of no-shunt and shunt patients well matched
for all known patient- and procedure-related characteristics.
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matched to any of the available no-shunt patients and
were therefore not included in the propensity-matched
analysis. There were no signiﬁcant differences in the 1072
matched pairs of no-shunt and shunt patients in any of
the known patient- or procedure-related characteristics
(Table II). Fig 1 demonstrates no signiﬁcant difference in
the 30-day postoperative mortality or combined stroke/
TIA rates for no-shunt and shunt patients from this
matched cohort. In addition, there was no signiﬁcant dif-
ference between the two groups from the matched cohort
in the percentage of postoperative neurologic deﬁcits that
were diagnosed on the day of operation (20% of no-
shunt patients who experienced postoperative stroke/TIA
vs 42% of shunt patients; P ¼ .32).
Of the 3151 patients in our overall study sample, 373
had severe stenosis (n ¼ 224) or occlusion (n ¼ 149) ofthe contralateral carotid artery on preoperative imaging
and might therefore be considered to be at high risk for
clamp-induced cerebral hypoperfusion during CEA. Of
these patients, 171 underwent CEA with and 202 without
an intraoperative shunt. Previously described propensity
score matching techniques were applied to this subgroup
and resulted in a cohort of 123 no-shunt and 123 shunt pa-
tients who were well matched for known patient- and
procedure-related variables (Table III). Fig 2 shows that
the shunt patients from this cohort had higher rates of
postoperative mortality (4.1% for shunt patients vs 0.8%
for no-shunt patients; P ¼ .10) and combined stroke/
TIA (9.8% for shunt patients vs 4.9% for no-shunt patients;
P ¼ .08), although these differences did not reach statistical
signiﬁcance.
DISCUSSION
In this study, we have compared the postoperative
neurologic outcomes of CEA patients with and without
intraoperative shunting who were well matched for a num-
ber of relevant patient- and procedure-related variables and
found that shunt use had no impact on 30-day postopera-
tive mortality or combined stroke/TIA rates. When similar
analyses were conﬁned only to those patients with severe
stenosis or occlusion of the contralateral carotid artery,
shunt use during CEA was associated with twofold greater
incidence of postoperative stroke/TIA. On the basis of
these ﬁndings, we reject the hypothesis that intraoperative
carotid shunt placement will reduce the incidence of peri-
operative stroke during CEA, even among those patients
who are at highest theoretical risk for clamp-induced cere-
bral hypoperfusion.
Few published studies have directly compared the out-
comes of CEA procedures that are performed with or
without intraoperative shunt use. Gumerlock and Neuwelt
Table III. Patient- and procedure-related characteristics of propensity-matched cohort of high-risk carotid
endarterectomy (CEA) patients, stratiﬁed by use of intraoperative shunting
No shunt (n ¼ 123) Shunt (n ¼ 123) P value
Patient age, years, mean 6 SD 70.0 6 9.3 70.5 6 9.3 .93
Female 49 (40) 45 (37) .57
Physiologic high-risk factors 7 (6) 5 (4) .48
Bleeding disorder 36 (29) 37 (22) .11
Ipsilateral ICA stenosis $80% 100 (81) 92 (75) .22
Type of preoperative symptoms .79
Asymptomatic 70 (57) 65 (53)
TIA or amaurosis fugax 30 (24) 33 (27)
Cerebrovascular accident 23 (19) 25 (20)
Degree of contralateral ICA stenosis .70
Severe (80%-99%) 76 (62) 73 (59)
Occlusion (100%) 47 (38) 50 (41)
Preprocedural antiplatelet 111 (90) 112 (91) .83
Preprocedural statin 95 (77) 98 (80) .63
Preprocedural b-blocker 77 (63) 76 (62) .89
Anatomic high-risk factors 45 (37) 48 (39) .60
Locoregional anesthesia 9 (7) 10 (8) .81
Operative time, minutes, median (IQR) 118 (95-144) 122 (89-158) .56
Patch angioplasty 115 (94) 108 (88) .07
ICA, Internal carotid artery; IQR, interquartile range; SD, standard deviation; TIA, transient ischemic attack.
Data are presented as number (%) unless otherwise indicated.
Fig 2. The30-day postoperative outcomes of propensity-matched
cohort of high-risk carotid endarterectomy (CEA) patients, strat-
iﬁed by use of intraoperative shunting. TIA, Transient ischemic
attack. *Based on McNemar c2 test comparing 123 pairs of no-
shunt and shunt patients with severe stenosis or occlusion of the
contralateral carotid artery who were well matched for all known
patient- and procedure-related characteristics.
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undergoing CEA with a shunt with those of 75 patients un-
dergoing the procedure without a shunt and found a signif-
icantly greater incidence of postoperative stroke in the
nonshunted group (8% vs 0.5%).17 The authors concluded
that shunt use reduced the risk of postoperative stroke,
although their trial lacked true randomization and there
was some imbalance in the preoperative characteristics of
the two groups. Conversely, Palombo et al compared the
outcomes in 96 CEA patients randomized to the use or
nonuse of an intraoperative shunt and observed no perioper-
ative strokes in either group.16 In addition, the authors re-
ported no difference between the two groups in the degree
of subtle cerebral damage postoperatively (as measured by
intraoperative neuroinﬂammatorymarker assays and postop-
erative neuropsychological testing), but patients with severestenosis or occlusion of the contralateral carotid artery were
excluded from the Palombo trial. Finally, Sandmann et al
demonstrated no signiﬁcant difference in the incidence of
postoperative stroke between 215 patients randomized to
undergo CEA with a shunt and 243 patients randomized to
undergo the procedure without a shunt (4.2% vs 3.3%; P ¼
not signiﬁcant).18 However, 45 additional patients from
that trial who initially underwent randomization to one or
another group were excluded from primary analysis either
because shunt placement was not technically possible or
because the results of intraoperative neurophysiologic testing
resulted in shuntuse even thoughapatienthadbeen random-
ized to the nonshunt arm of the study. An additional limita-
tion of that trial was the signiﬁcant proportion of patients
(43%) who required revision of the arteriotomy closure
because of suboptimal hemodynamics observed on post-
CEA intraoperative Doppler spectral analysis. These three
prospective studies were subjected to meta-analysis and
found to collectively provide insufﬁcient evidence to support
or to refute the use of routine shunting during CEA.6
Several other studies have reported the outcomes of
CEA performed with and without shunting but within
the context of comparing routine and selective shunting
strategies. For example, AbuRhama et al randomized 200
CEA patients to routine shunting vs shunt use dictated
by carotid systolic stump pressure.9 The 30-day postopera-
tive stroke rate for the 127 patients who received a shunt
(as part of either the routine or selective strategy) was
0%, whereas the rate for 73 patients whose carotid stump
pressures did not qualify them for shunts was 2.7%. The
authors concluded that either a routine or selective
approach to shunting was acceptable, but they were unable
to comment on the potential merits of a routine nonshunt-
ing approach. Of note, both of the postoperative strokes in
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did not undergo shunting, were determined on reoperation
to be the result of technical complications resulting in ipsi-
lateral carotid thrombosis and not due to clamp-induced
cerebral hypoperfusion. A second study by Goodney et al
examined the shunting practice patterns of surgeons
from the Vascular Study Group of New England in CEA
patients with contralateral carotid occlusion.15 The authors
analyzed the 30-day combined postoperative stroke/death
rates of three patient groups: those who received a shunt by
a surgeon who routinely shunts, those who received a
shunt by a surgeon who selectively shunts, and those
who did not receive a shunt. The authors classiﬁed individ-
ual surgeons as selective shunters if #95% of that surgeon’s
CEA patients received shunts. The combined stroke/death
rates were 1.5% for patients who were shunted by a routine
shunter, 3.4% for patients who were not shunted, and 7.6%
for patients who were shunted by a selective shunter (P ¼
.05 for trend). Because the expected stroke/death rates of
these three patient groups were similar, the authors of the
study concluded that intraoperative shunt use in patients
with contralateral carotid occlusion during CEA can reduce
their risk of adverse postoperative outcomes, but only when
it is placed by a surgeon who routinely places shunts.
Our analysis, among the largest to date to assess the
impact of shunting on neurologic outcomes after CEA,
demonstrates no discernible beneﬁt to shunt use. On the
contrary, the shunted patients in our matched cohort of
high-risk patients (ie, those with high-grade stenosis or oc-
clusion of the contralateral carotid artery) sustained a
twofold greater incidence of postoperative stroke/TIA
compared with the nonshunted patients, although this dif-
ference did not reach statistical difference. If the shunting
surgeons who contributed to our data set were predomi-
nantly selective instead of routine shunters and are there-
fore comparatively less experienced with shunt placement
techniques, this ﬁnding might reasonably be interpreted
as an argument against the practice of selective shunting
(instead of routine shunting or nonshunting). However,
our lack of knowledge about the individual practice pat-
terns of contributing surgeons precludes us from making
deﬁnitive conclusions about the comparative efﬁcacies of
the three different approaches to carotid shunting. Never-
theless, only a minority of the nonshunted patients in either
our overall study sample or in our subgroup of high-risk
patients who suffered perioperative stroke did so on the
day of their operation. This ﬁnding supports the results
of previous studies that have shown clamp-induced cerebral
hypoperfusion to be a relatively uncommon cause of peri-
operative stroke in CEA patients, even in those patients
with contralateral carotid occlusion.16,24,25
Our study has several limitations. The ﬁrst is our
inability to account for the practice patterns of individual
surgeons who performed the procedures that were
included for analysis. Thus, we are unable to ascertain
whether the outcomes achieved by surgeons who routinely
shunt during CEA might differ from those of surgeons who
shunt only selectively or if factors such as the patency statusof a patient’s vertebral arteries might have inﬂuenced the
decisions of individual surgeons to use a shunt during
CEA. Second, we were unable to determine if neurophys-
iologic monitoring was used during procedures that were
performed under general anesthesia and if such moni-
toring, when used, resulted in the placement of a shunt
because of either neurologic derangement or inadequate
stump pressure. Similarly, we do not know whether other
neuroprotective adjuncts, such as vasopressor-induced ce-
rebral hyperperfusion, might have been employed in no-
shunt patients during carotid arterial clamping or whether
the type of patch used in those patients who received patch
angioplasty after endarterectomy might have confounded
our comparison of the outcomes of shunt vs no-shunt pa-
tients. Although our propensity score matching algorithm
included several variables of particular import in consid-
ering the potential impact of shunt placement on CEA out-
comes, it is possible that shunt patients in the matched
cohorts of our study were at higher risk for perioperative
stroke in ways that we could not account for. Third, the
data source used for our analysis does not provide informa-
tion about the relative timing of cerebral ischemic events
and CEA. For this reason, we cannot adjust for the possi-
bility that intraoperative shunts were used preferentially
in patients with recent ischemic events who may be at
higher risk for adverse postoperative neurologic outcomes.
Similarly, the absence of hospital identiﬁers in the ACS
NSQIP PUFs prevents us from determining center-
speciﬁc postoperative outcomes or the annual volume of
CEA procedures for each of the centers that contributed in-
formation to the 2012 CEA-targeted data set. An additional
limitation of our analysis is that 58 shunt patients from our
original study sample were not included in the propensity-
matched analysis. However, given the relatively high rate
of postoperative stroke demonstrated for these 58 patients,
we ﬁnd it unlikely that modiﬁcation of our propensity
matching algorithm to capture these patients would signiﬁ-
cantly alter the conclusions of our study. Finally, although
the sample size of our study compares favorably with that
of other studies that have examined the impact of intraoper-
ative shunting on post-CEA outcomes, our conclusion of
“no difference” between the shunt and no-shunt groups
with respect to postoperative stroke rate is subject to a
high probability of type II error. This is particularly true
for our subgroup analysis of high-risk patients with severe
stenosis or occlusion of the contralateral carotid artery.
CONCLUSIONS
Recognizing these important limitations, the results of
our analysis suggest that intraoperative shunting during
CEA does not result in a reduction in the risk of perioper-
ative neurologic events, even in those patients who may be
at particularly high risk of clamp-induced cerebral hypoper-
fusion because of severe contralateral carotid disease. The
ﬁndings of our study therefore contribute to a growing
body of evidence suggesting that intraoperative shunting,
despite its theoretical beneﬁt, does not provide a discern-
ible clinical beneﬁt in patients who undergo CEA. The
JOURNAL OF VASCULAR SURGERY
102 Bennett et al January 2015potential impact of intraoperative shunting on post-CEA
outcomes merits revisiting in coming years as the size
and therefore statistical power of the CEA-targeted ACS
NSQIP database accrues more patients.
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